Background illustration for clinical trials search

Paid Clinical Trials Richmond

Discover 561 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Midlothian VA, Winchester VA, Durham NC, Newark DE,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase2, Phase3, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Midlothian VA, Greensboro NC, Gastonia NC, Florence SC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase3, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Midlothian VA, Norfolk VA, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

for
Type 2 Diabetes
Location: Midlothian VA, Burke VA, Canton OH, East Greenwich RI,
Sponsor: Housey Healthcare ULC

Sex: All

Age: 18+

Code: NCT07546929

Phase2, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

TERPS Trial for de Novo Oligometastic Prostate Cancer

for
Prostate Cancer, Oligometastatic Disease
Location: Midlothian VA, Glen Burnie MD, Columbia MD,
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18+

Code: NCT05223803

Phase2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for
Breast Cancer
Location: Midlothian VA, Bethesda MD, Philadelphia PA,
Sponsor: Celcuity Inc

Sex: All

Age: 18+

Code: NCT06757634

Phase3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Midlothian VA, Norfolk VA, Baltimore MD, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Midlothian VA, Charlottesville VA, Fairfax VA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Midlothian VA, Fort Belvoir VA, Fairfax VA, Bethesda MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Midlothian VA, Charlottesville VA, Norfolk VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting

Synvisc Injections for Lumbar Facet Joint Pain

for
Joint Pain
Location: Richmond VA
Sponsor: Sheltering Arms Physical Rehabilitation Hospitals

Sex: All

Age: 30+

Code: NCT00325845

Phase3, Recruiting

Utility of PharmacoGenomics for Reducing Adverse Drug Effects

for
Genetics of Drug Metabolism
Location: South Chesterfield VA, Arlington VA, Shippensburg PA,
Sponsor: Companion Dx Reference Lab, LLC

Sex: All

Age: 18+

Code: NCT02081872

Recruiting

CDR Investing in Fatherhood Process Study & Evaluation

for
Parenting, Parent-Child Relations
Location: Williamsburg VA
Sponsor: Child Development Resources

Sex: All

Age: 0+

Code: NCT03710135

Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer (SCLC)
Location: Williamsburg VA, Newport News VA, Hampton VA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase2, Phase3, Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for
Non-cystic Fibrosis Bronchiectasis
Location: Williamsburg VA, Washington D.C. DC, Chapel Hill NC,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase2, Recruiting

Shield Post-Approval Study Protocol

for
Colo-rectal Cancer
Location: Williamsburg VA, Chapel Hill NC, Hillsborough NC,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 45 - 70+

Code: NCT06880055

Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Williamsburg VA, Charlottesville VA, Brandywine MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Williamsburg VA, Norfolk VA, Baltimore MD, New Bern NC,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase2, Recruiting